![Thomas Lynch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Lynch
Corporate Officer/Principal chez
MINDWALK HOLDINGS CORP.
Fortune : 54 975 $ au 31/08/2026
Profil
Thomas W.
Lynch is currently Director at Bioforward, Inc. and Chief Business Officer at MindWalk Holdings Corp.
Starting in 2025, the role at MindWalk Holdings Corp.
began.
Formerly, Dr. Lynch was Vice President-Global Sales & Client Services at Aldevron LLC.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/07/2026 | 41 026 ( 0,09% ) | 54 975 $ | 31/08/2026 |
Postes actifs de Thomas Lynch
| Sociétés | Poste | Début |
|---|---|---|
| MINDWALK HOLDINGS CORP. | Corporate Officer/Principal | 20/10/2025 |
Bioforward, Inc.
 Bioforward, Inc. Investment ManagersFinance Alternative investment manager | Directeur/Membre du Conseil | - |
Anciens postes connus de Thomas Lynch
| Sociétés | Poste | Fin |
|---|---|---|
Aldevron LLC
 Aldevron LLC BiotechnologyHealth Technology Manufactures and develops biological science products | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
40
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Manufactures and develops biological science products | Health Technology |
Bioforward, Inc.
Bioforward, Inc. Investment ManagersFinance Alternative investment manager | Finance |
ImmunoPrecise Antibodies Ltd.
 ImmunoPrecise Antibodies Ltd. BiotechnologyHealth Technology Operates as AI-driven biotherapeutic research and technology firm that develops & discovers antibodies | Health Technology |
